S81052 |
LXR-623 ( WAY 252623) |
源葉(MedMol) | 98% |
品牌 | 貨號(hào) | 產(chǎn)品規(guī)格 | 價(jià)格(RMB) | 庫(kù)存(上海) | 北京 | 武漢 | 南京 | 數(shù)量 | 計(jì)量單位 | 加入購(gòu)物車(chē)... |
---|---|---|---|---|---|---|---|---|---|---|
源葉(MedMol) | S81052-5mg | 98% | ¥272.00元 | 9 | - | - | - | EA | 加入購(gòu)物車(chē) | |
源葉(MedMol) | S81052-10mg | 98% | ¥408.00元 | 預(yù)計(jì)交期:2-3天 | - | - | - | EA | 加入購(gòu)物車(chē) | |
源葉(MedMol) | S81052-50mg | 98% | ¥1428.00元 | 預(yù)計(jì)交期:2-3天 | - | - | - | EA | 加入購(gòu)物車(chē) |
- 提示:詳情請(qǐng)下載說(shuō)明書(shū)。
- 產(chǎn)品描述: LXR-623 is a brain-penetrant partial LXRα and full LXRβ agonist, with IC50s of 24 nM and 179 nM, respectively.
- 靶點(diǎn): IC50: 24 nM (LXR-α), 179 nM (LXR-β);LiverXReceptor
- 體內(nèi)研究:
LXR-623 (400 mg/kg, p.o.) crosses the blood-brain barrier, induces target gene expression, and achieves therapeutic levels in GBM cells in the brain with minimal activity in the periphery. LXR-623 inhibits tumor growth, promotes tumor cell death, and prolongs the survival of mice bearing intracranial patient-derived GBMs. LXR-623 (1.5, 5 mg/kg/day) significantly reduces progression of atherosclerosis in animals compared with the placebo group. WAY-252623 (15 and 50 mg/kg) results in a significant reduction of atherosclerosis in a dose-dependent manner. WAY-252623 (20, 60, and 120 mg/kg/day, p.o.) displays neutral lipid effects in this CETP-expressing Syrian hamster. Moreover, LXR-623 (50 mg/kg) induces gene expression in rodent peripheral blood cells in rat. LXR-623 (0, 15 and 50 mg/kg) dose-dependently upregulates transcription of ABCA1 and ABCG1 in monkey whole blood cells proportional to dose
- 參考文獻(xiàn):
1. Villa GR, et al. An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers. Cancer Cell. 2016 Nov 14;30(5):683-693. 2. Giannarelli C, et al. Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis. Eur Heart J. 2012 Jan;33(2):264-73. 3. Quinet EM, et al. LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse. J Lipid Res. 2009 Dec;50(12):2358-70. 4. DiBlasio-Smith EA, et al. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. J Transl Med. 2008 Oct 16;6:59.
- 溶解性: DMSO : ≥ 47 mg/mL (111.17 mM)
- 保存條件: RT
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 2.365 ml 11.827 ml 23.653 ml 5 mM 0.473 ml 2.365 ml 4.731 ml 10 mM 0.237 ml 1.183 ml 2.365 ml 50 mM 0.047 ml 0.237 ml 0.473 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶(hù)參考交流研究之用。
輸入產(chǎn)品批號(hào):
本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)
=**